Amicus Therapeutics Inc (FOLD) Insider Trading
- $71,123,425.77
- $145,122,652.45
- Nov. 6, 2024
- John F Crowley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 21, 2017 | CEO | 65,581 | $13.51 | Sell | $885,999.31 | |
Dec. 11, 2017 | CEO | 12,206 | $13.52 | Sell | $165,025.12 | |
Dec. 4, 2017 | CEO | 47,213 | $13.61 | Sell | $642,568.93 | |
Dec. 1, 2017 | Insider | 5,000 | $13.59 | Sell | $67,950.00 | |
Oct. 18, 2017 | CEO | 71,735 | $14.75 | Sell | $1,058,091.25 | |
Oct. 16, 2017 | CEO | 449,295 | $14.33 | Sell | $6,438,397.35 | |
Oct. 12, 2017 | Director | 10,000 | $14.25 | Sell | $142,500.00 | |
Oct. 12, 2017 | SVP | 7,000 | $14.25 | Sell | $99,750.00 | |
Oct. 12, 2017 | Insider | 50,194 | $14.25 | Sell | $715,264.50 | |
Oct. 12, 2017 | CFO | 40,000 | $14.25 | Sell | $570,000.00 | |
Sept. 26, 2017 | CEO | 1,395 | $14.36 | Buy | $20,032.20 | |
July 13, 2017 | Major Shareholder | 1,500,000 | $12.25 | Buy | $18,375,000.00 | |
June 19, 2017 | Insider | 30,000 | $10.00 | Sell | $300,000.00 | |
May 19, 2017 | Insider | 29,914 | $8.00 | Sell | $239,312.00 | |
March 2, 2017 | COO | 49,050 | $8.00 | Sell | $392,400.00 | |
Jan. 13, 2017 | Insider | 25,000 | $6.00 | Sell | $150,000.00 | |
Dec. 30, 2016 | Major Shareholder | 94,750 | $4.96 | Buy | $469,960.00 | |
Dec. 29, 2016 | Major Shareholder | 142,125 | $4.87 | Buy | $692,148.75 | |
Dec. 23, 2016 | Major Shareholder | 85,275 | $4.81 | Buy | $410,172.75 | |
Dec. 22, 2016 | Major Shareholder | 189,500 | $4.51 | Buy | $854,645.00 | |
Nov. 9, 2016 | SVP | 8,546 | $8.00 | Sell | $68,368.00 | |
Nov. 1, 2016 | Insider | 25,000 | $7.00 | Sell | $175,000.00 | |
Oct. 3, 2016 | Insider | 25,000 | $7.25 | Sell | $181,250.00 | |
Sept. 20, 2016 | CFO | 20,500 | $8.00 | Sell | $164,000.00 | |
Sept. 6, 2016 | Insider | 25,000 | $7.00 | Sell | $175,000.00 | |
Aug. 25, 2016 | Insider | 1,100,000 | $6.81 | Sell | $7,491,000.00 | |
Aug. 4, 2016 | Insider | 10,458 | $7.00 | Sell | $73,206.00 | |
July 27, 2016 | Insider | 20,916 | $7.00 | Sell | $146,412.00 | |
June 2, 2016 | General Counsel | 15,000 | $7.67 | Buy | $115,050.00 | |
Nov. 10, 2015 | Director | 10,000 | $10.27 | Buy | $102,700.00 | |
Oct. 7, 2015 | Major Shareholder | 50,000 | $6.27 | Buy | $313,500.00 | |
Oct. 6, 2015 | Major Shareholder | 750,000 | $6.71 | Buy | $5,032,500.00 | |
Oct. 1, 2015 | VP | 10,000 | $13.14 | Sell | $131,400.00 | |
Sept. 21, 2015 | COO | 13,001 | $16.78 | Sell | $218,156.78 | |
Sept. 21, 2015 | CFO | 15,236 | $16.78 | Sell | $255,660.08 | |
Sept. 15, 2015 | Insider | 25,000 | $17.75 | Sell | $443,750.00 | |
Sept. 14, 2015 | VP | 2,500 | $18.08 | Sell | $45,200.00 | |
July 16, 2015 | CEO | 16,025 | $16.00 | Sell | $256,400.00 | |
July 14, 2015 | CEO | 142,250 | $15.03 | Sell | $2,138,017.50 | |
July 13, 2015 | Director | 10,000 | $15.00 | Sell | $150,000.00 | |
July 13, 2015 | CEO | 7,750 | $15.01 | Sell | $116,327.50 | |
July 13, 2015 | SVP | 15,000 | $15.00 | Sell | $225,000.00 | |
July 8, 2015 | SVP | 6,250 | $13.87 | Sell | $86,687.50 | |
July 1, 2015 | SVP | 10,649 | $13.97 | Sell | $148,766.53 | |
July 1, 2015 | VP | 10,000 | $13.98 | Sell | $139,800.00 | |
June 23, 2015 | Director | 55,000 | $14.01 | Sell | $770,550.00 | |
June 22, 2015 | SVP | 18,981 | $13.94 | Sell | $264,595.14 | |
June 19, 2015 | SVP | 14,045 | $13.26 | Sell | $186,236.70 | |
June 19, 2015 | COO | 13,000 | $13.26 | Sell | $172,380.00 | |
June 19, 2015 | CFO | 15,235 | $13.26 | Sell | $202,016.10 |
Insiders are both buying and selling Amicus Therapeutics Inc stock.
The insider traders at Amicus Therapeutics Inc are: John F Crowley, Bradley L Campbell, Jay Barth, Hung Do, Burke W Whitman, Daphne Quimi, William D Baird III, Perceptive Advisors Llc, Ellen Rosenberg, Jeff Castelli, Samantha Prout, Margaret G Mcglynn, Michael Raab, David Michael Clark, Life Sciences Maste Perceptive, Kenneth Peist, Jayne Gershkowitz, Glenn Sblendorio, Julie Yu, Donald J Hayden Jr, Kurt J Andrews, Plc Glaxosmithkline, Ken Valenzano, Bradley L. Campbell, Enrique Dilone, William D. Baird III, Burke W. Whitman, Dipal Doshi, Joan Winterbottom, John F. Crowley, Lynn Dorsey Bleil, and Sol J Barer
The most active insider trader at Amicus Therapeutics Inc is John F Crowley with 110 trades.
Plc Glaxosmithkline has sold the most Amicus Therapeutics Inc stock with a total value of $119,721,428.50.
Perceptive Advisors Llc has bought the most Amicus Therapeutics Inc stock with a total value of $40,474,740.62.
The most recent insider trade for Amicus Therapeutics Inc was on Nov. 6, 2024.
The single biggest insider buy for Amicus Therapeutics Inc was from Life Sciences Maste Perceptive with a total value of $18,375,000.00 on July 13, 2017.
The single biggest insider sell for Amicus Therapeutics Inc was from Plc Glaxosmithkline with a total value of $59,860,714.25 on Oct. 27, 2014.